Treatment of Abdominal Abscesses With or Without Fibrinolysis

Sponsor
Children's Mercy Hospital Kansas City (Other)
Overall Status
Completed
CT.gov ID
NCT01597336
Collaborator
(none)
92
1
2
59
1.6

Study Details

Study Description

Brief Summary

The objective of this study is to evaluate the utility of fibrinolysis when draining an abdominal abscess as defined by length of stay after drainage.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Tissue plasminogen activator abscess flush
  • Procedure: Saline flush of abscess
N/A

Detailed Description

The hypothesis is that fibrinolysis of a abscess will shorten hospital stay compared to drainage alone.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
92 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Treatment of Abdominal Abscesses With or Without Fibrinolysis
Study Start Date :
Jun 1, 2009
Actual Primary Completion Date :
Jan 1, 2014
Actual Study Completion Date :
May 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Saline only flush of abscess

Saline alone used to flush abscess

Procedure: Saline flush of abscess
Thirteen ml of saline is used to flush abscess at time of drain placement and twice daily thereafter.
Other Names:
  • Standard saline flush of abscess
  • Experimental: Saline plus tPA flush of abscess

    Saline plus tPA used for abscess flush

    Procedure: Tissue plasminogen activator abscess flush
    Thirteen ml of 10% tPA in saline at time of drain and twice daily thereafter.
    Other Names:
  • fibrinolytic abscess flush
  • Outcome Measures

    Primary Outcome Measures

    1. Length of hospital stay [1-2 weeks]

      Length of time required for meeting discharge criteria

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients under age 18 found to have an abscess in their abdomen related to perforated appendicitis that requires a drain either prior to or after appendectomy.
    Exclusion Criteria:
    • Patients with known immune deficiency per medical record review

    • Patients with another condition affecting surgical decision making or recovery

    • Patients with drain unable to be placed

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's Mercy Hospital Kansas City Missouri United States 64108

    Sponsors and Collaborators

    • Children's Mercy Hospital Kansas City

    Investigators

    • Principal Investigator: Shawn D St. Peter, MD, Children's Mercy Hospital and Clinics

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Shawn St. Peter, Associate Professor, Children's Mercy Hospital Kansas City
    ClinicalTrials.gov Identifier:
    NCT01597336
    Other Study ID Numbers:
    • 11120126
    First Posted:
    May 14, 2012
    Last Update Posted:
    Feb 4, 2015
    Last Verified:
    Feb 1, 2015
    Keywords provided by Shawn St. Peter, Associate Professor, Children's Mercy Hospital Kansas City
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 4, 2015